Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05439031 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

StereoTactic Arrhythmia Radiotherapy in the NetherLands no. 2

Study acronym: STARNL-2
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Phase: Not applicable to Phase 2 Primary and study completion dates: Jul 2025 to Jul 2027v3 Show 1 more changeShow less
    • Primary and study completion dates: Jul 2025 to Jul 2027
  2. Phase: Phase 2 to Not applicable Trial status: Not Yet Recruiting to Recruiting · Start date changed from estimate of Jul 2022 to May 19, 2023 · Site details revisedv2 Show 3 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 2022 to May 19, 2023
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Ventricular tachycardia (VT) is a malignant cardiac arrhythmia subjecting our patients to a high risk of sudden death, increased morbidity and reduced quality of life. Unfortunately, failure of treatment is common and VT recurrences remain an important concern. In these patients, stereotactic arrhythmia radiotherapy appears to be an effective and safe treatment. The mechanism of action however remains unknown and should be elucidated. The objective of this phase 2, single arm, monocenter, pre-post intervention study is to evaluate the efficacy and safety of stereotactic arrhythmia radiotherapy and obtain insights in the mechanism of action by evaluating electro-anatomical alterations of stereotactic arrhythmia radiotherapy in patients with therapy refractory ventricular tachycardia.
Trial Details
NCT Number NCT05439031
Lead Sponsor Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborators: Dutch Heart Foundation
Conditions Ventricular Tachycardia, Arrythmia, Cardiac
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov